10 articles - From Friday Jun 24 2022 to Friday Jul 01 2022
Guidelines, position statements, white papers, technical reviews, consensus statements, etc…
meta-analyses and systematic reviews
RCT, clinical trials, retrospective studies, etc…
| Am J Clin Nutr |
Development and validation of a metabolite score for red meat intake: an observational cohort study and randomized controlled dietary intervention. The red meat metabolite score derived and validated in this study contains metabolites directly derived from meat consumption and is associated with T2D risk. These findings suggest the potential for objective assessment of dietary components and their application for understanding diet-disease associations.The trial in Lyon, France, was registered at clinicaltrials.gov as NCT03354130. |
Individualized high dairy protein + walking program supports bone health in pregnancy: a randomized controlled trial. Higher maternal dietary protein and calcium intakes compared to usual care in concert with normal vitamin D status minimized bone resorption and maintained bone formation and may protect bone health during pregnancy. Clinical Trial Registry NCT01689961 ( Registered on 21 September 2012. |
Mediators of weight change in underserved patients with obesity: exploratory analyses from the PROPEL cluster-randomized trial. In an underserved sample, weight change induced by an ILI compared to UC was mediated by several psychological and behavioral variables. These findings could help refine weight regimens in underserved patients with obesity. Clinical trial registry ClinicalTrials.gov number, NCT02561221. |
| Liver Transpl |
Graft aberrant hepatic arteries in deceased donor liver transplantation: the "one liver, one artery" approach. Retransplantation rates were 3.8%, 4% and 5.3% (p=0.685), respectively. In conclusion, a selective reconstruction policy of aHAs based on Doppler assessment of bilobar intraparenchymal arterial flow did not increase postoperative morbidity and avoided unnecessary and complex arterial reconstructions. |
Long-term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States. In conclusion, short- and long-term survival rates for HH are excellent and comparable to those of other LT recipients. Improving extrahepatic metabolic factors and functional status in HH patients prior to LT may improve outcomes. |
Low-dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation. Low-dose aspirin was associated with a lower risk of ACR and HAT after LT, especially in the first vulnerable year after transplantation. Therefore, low-dose aspirin use after primary LT should be evaluated to protect the liver graft from ACR and to maintain arterial patency. |
Neonates with acute liver failure have higher overall mortality but similar post-transplant outcomes as older infants. We present the largest multi-center study on peri-transplant outcomes in neonatal ALF and show similar risk factors for death or transplant in neonates compared to older infants. Despite lower transplantation rates, neonates demonstrate similar post-transplant outcomes as older infants. Further studies are needed to better risk stratify neonates eligible for transplant and improve outcomes. |
| Pancreatology |
Plenty of the editorials are available as full text through the publisher website using the provided link
Letters to the editors and authors’ replies